Cambridge Investment Research Advisors
SGYP

Cambridge Investment Research Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,150
Closed -$87K – 2276
2017
Q4 		$87K Sell
39,150
-75,375
-66% -$187K ﹤0.01% 2037
2017
Q3 		$332K Sell
114,525
-34,550
-23% -$118K ﹤0.01% 1485
2017
Q2 		$663K Sell
149,075
-9,000
-6% -$37.1K 0.01% 1033
2017
Q1 		$737K Sell
158,075
-1,500
-0.9% -$8.7K 0.01% 874
2016
Q4 		$972K Sell
159,575
-3,000
-2% -$15.7K 0.02% 691
2016
Q3 		$896K Sell
162,575
-37,400
-19% -$175K 0.02% 737
2016
Q2 		$760K Sell
199,975
-20,834
-9% -$70.6K 0.02% 742
2016
Q1 		$609K Sell
220,809
-27,480
-11% -$99.5K 0.01% 793
2015
Q4 		$1.41M Sell
248,289
-2,875
-1% -$17.5K 0.03% 444
2015
Q3 		$1.33M Sell
251,164
-1,000
-0.4% -$7.74K 0.04% 400
2015
Q2 		$2.09M Sell
252,164
-17,641
-7% -$85.5K 0.06% 306
2015
Q1 		$1.25M Sell
269,805
-33,900
-11% -$110K 0.04% 435
2014
Q4 		$926K Sell
303,705
-88,965
-23% -$263K 0.03% 517
2014
Q3 		$1.09M Sell
392,670
-32,320
-8% -$117K 0.03% 485
2014
Q2 		$1.73M Sell
424,990
-16,300
-4% -$69.3K 0.06% 307
2014
Q1 		$2.34M Sell
441,290
-25,824
-6% -$145K 0.09% 222
2013
Q4 		$2.59M Buy
467,114
+11,747
+3% +$50.7K 0.11% 178
2013
Q3 		$2.05M Buy
455,367
+78,336
+21% +$351K 0.09% 214
2013
Q2 		$1.61M Buy
+377,031
New +$1.89M 0.08% 228

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Cambridge Investment Research Advisors's SGYP Position: Q1 2018 in Review

Cambridge Investment Research Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 39,150 shares — an estimated $87K sold.

Cambridge Investment Research Advisors first reported a position in SGYP in Q2 2013 and held it in 19 quarters. The position peaked at $2.59M in Q4 2013. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • Cambridge Investment Research Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 39,150 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $87K.
  • Cambridge Investment Research Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 19 quarters.
  • Cambridge Investment Research Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.59M in Q4 2013.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.